Lv21
180 积分 2024-05-27 加入
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies
1个月前
已完结
Backfilling Patients in Phase I Dose-Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
1个月前
已完结
Survodutide Once Weekly for the Treatment of Adults with Obesity
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已关闭
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Cardiac safety of chronic inhibition of the myostatin–activin pathway with bimagrumab in healthy older adults
2个月前
已关闭
A clinical review on third and fourth generation EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
2个月前
已完结
Recent advances of novel fourth generation EGFR inhibitors in overcoming C797S mutation of lung cancer therapy
2个月前
已完结
Exploring 4th generation EGFR inhibitors: A review of clinical outcomes and structural binding insights
2个月前
已完结
皖公网安备34019202002308
